Relitrexed-500 Injection 1's

Relitrexed-500 Injection 1's belongs to the group of medicines called folate analogue metabolic inhibitors used alone or in combination with other anti-cancer medicines to treat non-small cell lung cancer and malignant pleural mesothelioma (cancer affecting the lining of the lung). 
 
Relitrexed-500 Injection 1's contains Pemetrexed, which works by blocking the action of substances that may help the cancer cells multiply.
 
In some cases, Relitrexed-500 Injection 1's may cause side effects such as diarrhoea, tiredness, nausea, vomiting, and loss of appetite. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
 
Do not use Relitrexed-500 Injection 1's if you are pregnant or breastfeeding. Relitrexed-500 Injection 1's is not recommended for children below 18 years. Women and men should use effective contraception during treatment with Relitrexed-500 Injection 1's and for 6 and 3 months afterwards. Inform your doctor about your health condition and medications to rule out any side effects/interactions.

Relitrexed-500 Injection 1's contains Pemetrexed, which belongs to the group of medicines called anti-folate anti-neoplastic agents indicated in the treatment of malignant pleural mesothelioma and non-small cell lung cancer in initial treatment in combination with cisplatin, as maintenance treatment of patients whose disease has not progressed after four cycles of platinum-based first-line chemotherapy and after prior chemotherapy as a single agent. Relitrexed-500 Injection 1's treats cancer by blocking the action of substances that may help the cancer cells multiply.

• Nausea
• Vomiting
• Loss of appetite
• Tiredness
• Pain, redness, swelling or sores in the mouth
• Infection
• Sore throat
• Low white blood cells, haemoglobin levels
• Skin rash
• Flaking skin

Do not use Relitrexed-500 Injection 1's if you are allergic to any of its components, pregnant or breastfeeding, or if you have taken or plan to receive yellow fever vaccination. Inform the doctor if you have/had heart disease, kidney problems, have had or are going to have radiation therapy, or have accumulation of fluid around the lungs. Seek immediate medical attention if you experience symptoms of fever or infection; pain, sores, redness or swelling in the mouth; chest pain or a fast heartbeat; allergic reaction (skin rash, burning/prickling sensation, or fever); Stevens-Johnson Syndrome or toxic epidermal necrolysis (severe rash, itching, or blistering); low haemoglobin levels (tiredness, feeling faint, paleness, or becoming easily breathless); low platelet count (bleeding from gums/nose/mouth, bleeding that does not stop, unexpected bruising, reddish or pinkish urine); or blood clot in the blood vessels of the lungs (sudden breathlessness, cough with bloody sputum or intense chest pain).

• IBUPROFEN

• The doctor may advise blood tests to evaluate your liver/kidney function and blood cell count.
• Women must use effective contraception during treatment and for six months after receiving the last dose.
• Men are advised to use effective contraception during treatment and for three months after the end of the treatment. 
• You are recommended to take the supplements as advised by the doctor.

• Eat a healthy diet and exercise regularly to maintain proper weight.
• Avoid smoking and alcohol consumption.
• Include vegetables and fruits in your diet.
• Avoid fast food, fried, processed food, refined carbs, and added sugar.
• Get optimal sleep; rest well.
• Drink enough water and eat fibre-rich foods, vegetables and fruits.